» Articles » PMID: 38356197

ESKAPE in China: Epidemiology and Characteristics of Antibiotic Resistance

Overview
Date 2024 Feb 15
PMID 38356197
Authors
Affiliations
Soon will be listed here.
Abstract

The escalation of antibiotic resistance and the diminishing antimicrobial pipeline have emerged as significant threats to public health. The ESKAPE pathogens - Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp. - were initially identified as critical multidrug-resistant bacteria, demanding urgently effective therapies. Despite the introduction of various new antibiotics and antibiotic adjuvants, such as innovative β-lactamase inhibitors, these organisms continue to pose substantial therapeutic challenges. People's Republic of China, as a country facing a severe bacterial resistance situation, has undergone a series of changes and findings in recent years in terms of the prevalence, transmission characteristics and resistance mechanisms of antibiotic resistant bacteria. The increasing levels of population mobility have not only shaped the unique characteristics of antibiotic resistance prevalence and transmission within People's Republic of China but have also indirectly reflected global patterns of antibiotic-resistant dissemination. What's more, as a vast nation, People's Republic of China exhibits significant variations in the levels of antibiotic resistance and the prevalence characteristics of antibiotic resistant bacteria across different provinces and regions. In this review, we examine the current epidemiology and characteristics of this important group of bacterial pathogens, delving into relevant mechanisms of resistance to recently introduced antibiotics that impact their clinical utility in China.

Citing Articles

Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.

Zhao T, Chen N, Zhang M, Lin L, Lin B, Fang Y Front Microbiol. 2025; 16:1532231.

PMID: 40046300 PMC: 11880276. DOI: 10.3389/fmicb.2025.1532231.


Shifting of Distribution and Changing of Antibiotic Resistance in Gram-Positive Bacteria from Bile of Patients with Acute Cholangitis.

Hao Y, Li L, Du W, Lu J Infect Drug Resist. 2025; 18:1187-1197.

PMID: 40034266 PMC: 11874747. DOI: 10.2147/IDR.S482375.


Epidemiology and Genetic Traits of Carbapenemase-Producing Enterobacterales: A Global Threat to Human Health.

Alvisi G, Curtoni A, Fonnesu R, Piazza A, Signoretto C, Piccinini G Antibiotics (Basel). 2025; 14(2).

PMID: 40001385 PMC: 11852015. DOI: 10.3390/antibiotics14020141.


Microbial Colonization and Antibiotic Resistance Profiles in Chronic Wounds: A Comparative Study of Hidradenitis Suppurativa and Venous Ulcers.

Sandru F, Poenaru E, Stoleru S, Radu A, Roman A, Ionescu C Antibiotics (Basel). 2025; 14(1).

PMID: 39858339 PMC: 11759762. DOI: 10.3390/antibiotics14010053.


Molecular Epidemiological Characteristics of -Carrying ST-11 in Hospitalized Patients.

Xue Y, Zhang D, Du S, Chen D, Liu S, Peng T Infect Drug Resist. 2025; 18():171-184.

PMID: 39803303 PMC: 11725253. DOI: 10.2147/IDR.S482713.


References
1.
Hung W, Wan T, Kuo Y, Yamamoto T, Tsai J, Lin Y . Molecular Evolutionary Pathways toward Two Successful Community-Associated but Multidrug-Resistant ST59 Methicillin-Resistant Staphylococcus aureus Lineages in Taiwan: Dynamic Modes of Mobile Genetic Element Salvages. PLoS One. 2016; 11(9):e0162526. PMC: 5015870. DOI: 10.1371/journal.pone.0162526. View

2.
Hamidian M, Nigro S . Emergence, molecular mechanisms and global spread of carbapenem-resistant . Microb Genom. 2019; 5(10). PMC: 6861865. DOI: 10.1099/mgen.0.000306. View

3.
Ding L, Hu F . China's new national action plan to combat antimicrobial resistance (2022-25). J Antimicrob Chemother. 2022; 78(2):558-560. DOI: 10.1093/jac/dkac435. View

4.
Li L, Zhang H, Zhang J, Xiao Y, Li Y, Qu J . TEMPORARY REMOVAL: The first investigation of a nosocomial outbreak caused by ST80 vancomycin-resistant Enterococci faecium in China. J Hosp Infect. 2023; . DOI: 10.1016/j.jhin.2023.10.020. View

5.
Uehara Y . Current Status of Staphylococcal Cassette Chromosome (SCC). Antibiotics (Basel). 2022; 11(1). PMC: 8772726. DOI: 10.3390/antibiotics11010086. View